Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00384150 · TERMINATED

Trial details

NCT number: NCT00384150
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's

Start date: 2007-11-01
Primary completion: 2010-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.